Pharmacy tool aims to curb opioid abuse
NCT ID NCT05706311
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study develops and tests a computer tool that helps pharmacists screen patients for opioid medication risks. Researchers will compare pharmacies using the tool to those using standard care. The goal is to see if the tool lowers patients' risk of opioid abuse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Jan 2025
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A large chain retail pharmacy chain in the Cincinnati or Columbus, Ohio area Exclusion Criteria: * None This study does not involve individual patients as randomization will occur among pharmacies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Opioid abuse are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to beat opioid relapse: new study tests Non-Invasive technique
- Can school programs curb teen drug use? cherokee nation trial seeks answers
- Small study probes brain effects of mixing opioids and benzodiazepines
- Rural ERs get a lifeline: poison center telehealth aims to start opioid treatment on the spot
- Can brain wiring predict opioid relapse? yale launches 240-Person study
- Doctor alert letters aim to curb opioid overprescribing